We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMBK icon
2526
SmartFinancial
SMBK
$898M
$212K ﹤0.01%
15,599
+9,833
+171% +$139K
CW icon
2527
Curtiss-Wright
CW
$26.7B
$211K ﹤0.01%
2,259
-9,089
-80% -$872K
EBTC
2528
DELISTED
Enterprise Bancorp
EBTC
$211K ﹤0.01%
10,031
+8,015
+398% +$174K
G icon
2529
Genpact
G
$5.7B
$211K ﹤0.01%
+5,420
New +$214K
RTH icon
2530
VanEck Retail ETF
RTH
$259M
$211K ﹤0.01%
1,420
-1,231
-46% -$178K
ABMD
2531
DELISTED
Abiomed Inc
ABMD
$211K ﹤0.01%
763
-3,933
-84% -$1.13M
ATRO icon
2532
Astronics
ATRO
$4.34B
$210K ﹤0.01%
32,723
+28,123
+611% +$214K
BLBD icon
2533
Blue Bird Corp
BLBD
$2.04B
$210K ﹤0.01%
17,267
+13,715
+386% +$172K
FDBC icon
2534
Fidelity D&D Bancorp
FDBC
$322M
$210K ﹤0.01%
4,319
+3,594
+496% +$172K
KMPR icon
2535
Kemper
KMPR
$1.56B
$210K ﹤0.01%
3,144
-4,441
-59% -$337K
UTHR icon
2536
United Therapeutics
UTHR
$21.9B
$210K ﹤0.01%
2,079
-5,327
-72% -$585K
CDZI icon
2537
Cadiz
CDZI
$292M
$209K ﹤0.01%
21,008
+17,581
+513% +$179K
CURE icon
2538
Direxion Daily Healthcare Bull 3X ETF
CURE
$190M
$209K ﹤0.01%
3,309
-9,801
-75% -$615K
QSR icon
2539
Restaurant Brands International
QSR
$26.1B
$209K ﹤0.01%
3,632
-9,703
-73% -$541K
APRE icon
2540
Aprea Therapeutics
APRE
$8.46M
$208K ﹤0.01%
433
+360
+493% +$201K
CIVI
2541
DELISTED
Civitas Resources
CIVI
$208K ﹤0.01%
11,075
+9,829
+789% +$184K
GWRE icon
2542
Guidewire Software
GWRE
$14.4B
$207K ﹤0.01%
1,985
+1,859
+1,475% +$209K
XBIT icon
2543
XBiotech
XBIT
$75M
$207K ﹤0.01%
10,840
+8,369
+339% +$144K
HMHC
2544
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$207K ﹤0.01%
119,621
+91,432
+324% +$204K
BFST icon
2545
Business First Bancshares
BFST
$1.05B
$206K ﹤0.01%
13,707
+11,331
+477% +$162K
RGCO icon
2546
RGC Resources
RGCO
$225M
$206K ﹤0.01%
8,780
+7,101
+423% +$167K
VLGEA icon
2547
Village Super Market
VLGEA
$627M
$206K ﹤0.01%
8,349
+6,692
+404% +$172K
FRGI
2548
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$206K ﹤0.01%
21,997
+16,683
+314% +$145K
ACNB icon
2549
ACNB Corp
ACNB
$656M
$205K ﹤0.01%
9,825
+8,154
+488% +$181K
DEI icon
2550
Douglas Emmett
DEI
$1.95B
$205K ﹤0.01%
8,182
-19,259
-70% -$543K
100 101
102
103 104

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.